A new study has found that initial visits and the number of viral load tests decreased during the COVID-19 pandemic but viral suppression and hospitalizations remained stable.
The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.The article also highlights that the preliminary efficacy results show that ApTOLL significantly reduces mortality and long-term functional dis.
In the PHERGAIN trial, nearly all patients who were diverted from chemotherapy prior to surgery for HER2-positive early breast cancer survived without cancer recurrence for 3 years.
/PRNewswire/ Hisense, a manufacturer and provider of high-performance electronics and medical devices, recently participated at Spain s University Hospital.